Whereas Valenti el al showed an association between this polymorphism and NAFLD histologic severity [15], another study [16] found an association only with the age at the presentation of NAFLD, not supporting the clinical utility of PNPLA3 genotyping for risk stratification [17]. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.